Free call 0800 52 00 161 / Existing patients: 0207 078 4868
Patient Portal
UK
Brasil Chile Deutschland España France International Italia Panamá Portugal Russia UK

50% off our Diagnostic Package

Book Now
IVI UK
    • Fertility diagnosis

      • The IVI Diagnostic Pack
      • MUMS² Pack
      • Fertility Assessments
      • Starting Fertility Treatment
    • ASSISTED REPRODUCTION

      • Intrauterine Insemination (IUI)
      • In Vitro Fertilisation (IVF)
      • Reciprocal IVF
      • Egg Donation
      • Preserving Fertility
    • OUR RESULTS

      • Success Rates
    • ANSWER YOUR QUESTIONS

      • Causes of Infertility
      • Your First Visit
      • Fertility Treatment After 40
      • Fertility Treatment for Single Women
      • Fertility treatment for LGBTQ+ couples
      • Endometriosis
      • Polycystic Ovary Syndrome (PCOS) Guide
      • Events on demand
    • ADVANCED TECHNIQUES

      • Intracytoplasmic Sperm Injection (ICSI)
      • EmbryoScope
      • Vitrification of oocytes
    • GENETIC TESTS

      • PGT-A / PGS
      • PGT-M / PGT-SR
  • Prices
    • UK

      • London
    • Donor Programme Overseas

      • Egg Donation Program in Spain
  • Services for NHS Patients
    • SPECIALISTS

      • Medical team
    • CONTENTS

      • Blog
      • The Language of fertility
      • Press room
      • Why Choose IVI
Make an appointment
  • Fertility diagnosis

    • The IVI Diagnostic Pack
    • MUMS² Pack
    • Fertility Assessments
    • Starting Fertility Treatment
  • ASSISTED REPRODUCTION

    • Intrauterine Insemination (IUI)
    • In Vitro Fertilisation (IVF)
    • Reciprocal IVF
    • Egg Donation
    • Preserving Fertility
  • OUR RESULTS

    • Success Rates
  • ANSWER YOUR QUESTIONS

    • Causes of Infertility
    • Your First Visit
    • Fertility Treatment After 40
    • Fertility Treatment for Single Women
    • Fertility treatment for LGBTQ+ couples
    • Endometriosis
    • Polycystic Ovary Syndrome (PCOS) Guide
    • Events on demand
  • ADVANCED TECHNIQUES

    • Intracytoplasmic Sperm Injection (ICSI)
    • EmbryoScope
    • Vitrification of oocytes
  • GENETIC TESTS

    • PGT-A / PGS
    • PGT-M / PGT-SR
Prices
  • UK

    • London
  • Donor Programme Overseas

    • Egg Donation Program in Spain
Services for NHS Patients
  • SPECIALISTS

    • Medical team
  • CONTENTS

    • Blog
    • The Language of fertility
    • Press room
    • Why Choose IVI
Free call
Request information
4 July 2022

New AI study achieves 90% accuracy in the selection of chromosomally normal embryos

Applying AI to embryo selection
Home Blog New AI study achieves 90% accuracy in the selection of chromosomally normal embryos
By the Editorial Committee IVI Blog

  • A pioneering study from IVI combines five modules of embryo image analysis using AI to detect the number of chromosome sets in a cell
  • 2,500 embryos have been analysed, offering a revolutionary technique in the field of embryology, which is non-invasive, universal, standardised, automatic and improves all current methods of embryo selection

Within the framework of the 38th Congress of the European Society of Human Reproduction and Embryology (ESHRE), Milan, 3 – 6 July 2022

Artificial Intelligence (AI) is here to stay. Its promising results in social, political, economic and even scientific fields give AI a preferential place, for which interest and applications are growing at a dizzying pace.

This context is the ideal framework for the study, ‘Artificial intelligence (AI) based triage for preimplantation genetic testing (PGT); an AI model that detects novel features in the embryo associated with ploidy’, presented at the 38th edition of the Congress of the European Society of Human Reproduction and Embryology (ESHRE) led by Dr. Marcos Meseguer, embryologist and scientific supervisor of IVI Valencia.

“This is a pioneering study, since, for the first time in the world, we have developed and combined five independent modules that analyse embryo characteristics using computer vision, thus achieving an accuracy of 90% in the prediction of chromosomally normal embryos. Being able to evaluate embryo implantation potential in this way allows us to improve the efficiency of a fundamental process in assisted reproduction, embryo culture and embryo selection”, explained Dr. Meseguer.

This percentage of accuracy is unprecedented, coming close to that obtained by invasive genetic testing necessitating embryo biopsy. AI offers the possibility of studying the embryo through complex algorithms that circumvent the need to extract cells through manipulation, thus being able to successfully select viable embryos for transfer during IVF treatment.

“The germ of this study responds to an unquestionable reality: embryonic development does not occur in the same way in euploid – chromosomally normal – embryos and aneuploid – chromosomally abnormal – embryos. At this point, could AI predict ploidy? The five modules that we have been able to analyse and combine show us that yes, it would be possible and reliable”, added Dr. Meseguer.

The study analysed 2,500 embryos – the most extensive scientific case study in the world – resulting in a revolutionary technique in the field of embryology, which is non-invasive, universal, standardised, automatic and would improve all current methods of embryo selection.

The five modules studied are:

Table of Contents

Toggle
  • 1) Morphokinetic parameters
  • 2) Embryo morphology
  • 3) Cell activity
  • 4) Mitochondrial activity
  • 5) Warping/shrinkage

1) Morphokinetic parameters

This module refers to the times at which the most important events of embryonic development occur, i.e. when the embryo divides and accumulates multiple cells until it reaches the blastocyst stage. “By simply analysing these parameters in the 2,500 embryos studied, we have been able to verify that, taking an euploid embryo as a reference, if another embryo arrives later at an event, its probability of being aneuploid increases considerably”, explains Dr. Meseguer.

2) Embryo morphology

An automated analysis of this parameter shows that embryos with good morphology are more likely to be chromosomally normal. The morphology itself has a predictive capacity of 68% for aneuploidy.

3) Cell activity

This module consists of measuring the diameter of a cell and the summation of all diameters of all cells of an embryo at a specific moment in its development (normally between 2 to 8 cells). “This automatically calculates values that are then analysed for 160 images, resulting in chromosomally abnormal or aneuploid embryos with a longer diameter length. This is because they take longer to split, the splitting produces many movements and thus increases the measurement”, adds Dr. Meseguer.

4) Mitochondrial activity

This involves associating the smallest analysable size as regards the image, which is a pixel, with the size of a mitochondrion. Subsequently, the embryo’s pixels are quantified and the changes in quantity and distribution are analysed, comparing them between euploid and aneuploid embryos. Aneuploid embryos have a different number of pixels than euploid embryos, so this module helps predict aneuploidy with 77% accuracy.

5) Warping/shrinkage

Shrinkage occurs in approximately 20% of embryos. After analysing this event using an automated examination, it is observed to occur more frequently in aneuploid embryos.

“In short, computer vision allows us to emulate our eyes’ capabilities on computers. In other words, it aims to acquire, process, analyse and understand images of the real world in order to produce numerical or symbolic information that can be processed by a computer. And this ultimately allows us to check that embryos behave differently during their development according to their chromosomal content and thus optimise the process of embryo study and the selection of normal and viable embryos for transfer”, concluded Dr. Meseguer.

As a result, the combination of these five modules together with a complex algorithm developed by IVI Valencia in collaboration with the Israeli company AiVF would result in an accuracy of 90% in the selection of chromosomally normal embryos. This would have a direct impact on an increase in pregnancy rates, which would provide an objective and reliable prediction using this fast and economical method.

No related posts.

Featured articles
Cramps but No Period: Possible causes
3 August 2023
Cramps but No Period: Possible causes
How early can you take a pregnancy test?
10 May 2023
How early can you take a pregnancy test?
Infertility: Why don’t more people talk about it?
3 April 2020
Infertility: Why don’t more people talk about it?
Everything You Need to Know About Getting Pregnant at 40
1 February 2018
Everything You Need to Know About Getting Pregnant at 40
Assisted reproduction treatments
  • Intrauterine Insemination (IUI)
  • In Vitro Fertilisation (IVF)
  • Egg Donation
  • Donor Programme Overseas

  • Fertility Clinics
  • Clinic IVI London
  • Request more information, no obligation

    Sending

    Thank you,

    One of our agents will contact you shortly. Meanwhile, have a look at our Virtual Events on Demand, in which you can find exclusive content about the fertility treatments we offer.

    Access the fertility days

    Comments are closed here.

    Experts in fertility

    • Infertility Treatments
    • The IVI Diagnostic Pack
    • IVI London
    • FAQs

    Learn about us

    • Corporate information
    • IVIRMA Global Education
    • IVIRMA Innovation
    • Jobs at IVI
    • Legal Notice
    • Cookies Policy
    • Complaints policy
    • Treatment Terms & Conditions
    • logo
    • logo
    • logo
    • logo
    • logo

    Head Offices

    • Calle Colón 1, 4ª planta, 46004 Valencia. España.

    London Clinic

    • 83 Wimpole Street W1G 9RQ - London